Cidara Therapeutics, Inc.
CDTX
$22.05
-$0.31-1.39%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 49.02% | -22.50% | 466.44% | -18.89% | -26.49% |
| Total Receivables | -0.29% | -27.67% | -67.74% | -48.27% | 392.99% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -53.53% | 1,380.53% | -42.74% | 90.77% | -53.88% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 34.42% | -7.01% | 259.97% | -23.04% | 5.46% |
|
|
|||||
| Total Current Assets | 34.42% | -7.01% | 259.97% | -23.04% | 5.46% |
| Net Property, Plant & Equipment | -8.22% | -7.44% | -4.70% | -4.53% | 8.83% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -92.27% | 1,094.23% | -89.46% | -5.82% | -0.47% |
| Total Assets | 32.32% | -6.36% | 228.85% | -21.35% | 5.61% |
|
|
|||||
| Total Accounts Payable | 21.60% | 29.68% | -54.74% | 34.01% | 3.03% |
| Total Accrued Expenses | 11.34% | 11.08% | 3.59% | -7.16% | 129.53% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.86% | 3.88% | 3.96% | 12.62% | 23.69% |
| Total Finance Division Other Current Liabilities | -- | -- | -99.95% | -3.07% | 70.96% |
| Total Other Current Liabilities | -- | -- | -99.95% | -3.07% | 70.96% |
| Total Current Liabilities | 11.76% | 11.85% | -39.41% | -2.96% | 89.27% |
|
|
|||||
| Total Current Liabilities | 11.76% | 11.85% | -39.41% | -2.96% | 89.27% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -18.12% | -14.97% | -12.72% | -11.01% | 8.20% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -55.52% | -74.28% |
| Total Liabilities | 10.25% | 10.09% | -39.82% | -6.31% | 35.74% |
|
|
|||||
| Common Stock & APIC | 14.82% | 0.10% | 55.29% | 0.17% | 0.21% |
| Retained Earnings | -9.36% | -2.94% | -20.19% | -2.34% | -4.04% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 41.23% | -11.69% | 836.42% | -116.57% | -202.14% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 41.23% | -11.69% | 836.42% | -116.57% | -202.14% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 41.23% | -11.69% | 836.42% | -116.57% | -202.14% |
|
|
|||||
